Rossella Cannarella | Medicine and Dentistry | Women Research Award

Women Research Award

Rossella Cannarella
Università degli Stufi di Catania, Italy

Rossella Cannarella
Affiliation Università degli Stufi di Catania
Country Italy
Scopus ID 56033761100
Documents 294
Citations 5,229
h-index 40
Subject Area Medicine and Dentistry
Event International Research Excellence Awards – Book of Award
ORCID 0000-0003-4599-8487

Rossella Cannarella is an Italian researcher whose scholarly work has contributed to the advancement of reproductive medicine, endocrinology, and andrology. With an extensive publication portfolio and substantial citation impact, her research has addressed clinically relevant topics including male infertility, hormonal disorders, assisted reproduction, environmental influences on reproductive health, and metabolic disease management. Her academic profile demonstrates sustained productivity and international visibility, making her a noteworthy candidate for recognition through the Women Research Award program.[1]

Abstract

This article presents an academic overview of Rossella Cannarella and her contributions to medicine and dentistry. Her work encompasses translational and clinical research focused on reproductive health, endocrinology, diabetes management, and fertility preservation. Through numerous peer-reviewed publications, she has contributed evidence supporting improved patient outcomes and expanded understanding of reproductive disorders and treatment strategies.[2]

Keywords

Reproductive Medicine, Andrology, Endocrinology, Male Infertility, Diabetes Care, Clinical Research, Women’s Research Award, Translational Medicine.

Introduction

Modern reproductive medicine increasingly relies on multidisciplinary investigation integrating genetics, endocrinology, clinical medicine, and public health. Rossella Cannarella has contributed to these interconnected domains through studies examining fertility disorders, hormonal regulation, environmental toxicology, and therapeutic interventions. Her scholarly record reflects continued engagement with emerging challenges affecting reproductive and metabolic health worldwide.[3]

Research Profile

With 294 indexed documents, 5,229 citations, and an h-index of 40, Cannarella has established a measurable scholarly presence. Her research profile demonstrates sustained publication activity in reputable international journals covering reproductive biology, clinical endocrinology, molecular genetics, and patient-centered healthcare outcomes. These metrics indicate both productivity and scientific influence within her field.[1]

Research Contributions

Her investigations have explored genetic determinants of congenital hypogonadotropic hypogonadism, the impact of environmental contaminants on sperm function, and comparative effectiveness of reproductive interventions. Additional studies have examined fertility outcomes, sperm quality, and endocrine therapies, contributing evidence that supports clinical decision-making and patient management.[4][5]

Publications

  • Transitioning to Omnipod 5®: Effectiveness, Safety, and Patient-Reported Outcomes of a Tubeless Automated Insulin Delivery System in Adults with Type 1 Diabetes Mellitus (2026).
  • Identification of Novel Genetic Variants in a Cohort of Congenital Hypogonadotropic Hypogonadism: Computational Analysis of Pathogenicity Predictions (2025).
  • Comparison Between Varicocelectomy and Varicocele Sclerotherapy: Results of a Single-Center Observational Study (2024).
  • Effects of Switching FSH Preparations on Sperm Parameters and Pregnancy: A Prospective Controlled Study (2024).
  • In-Vitro Effects of Perfluorooctanoic Acid on Human Sperm Function: What Are the Clinical Consequences? (2024).

Research Impact

The impact of Cannarella’s scholarship is reflected in citation metrics, interdisciplinary collaborations, and the translational relevance of her findings. Her publications address practical healthcare concerns while simultaneously advancing scientific understanding. Research on fertility treatments, genetic diagnosis, and environmental health factors has provided valuable evidence for clinicians and researchers working across reproductive medicine specialties.[6]

Award Suitability

The Women Research Award recognizes researchers who demonstrate scientific excellence, sustained productivity, and meaningful contributions to knowledge advancement. Based on her publication record, citation performance, leadership in reproductive medicine research, and commitment to evidence-based healthcare, Rossella Cannarella aligns with key criteria commonly associated with international academic recognition programs. Her work illustrates the role of women researchers in addressing complex biomedical challenges and improving healthcare outcomes.[1]

Conclusion

Rossella Cannarella has developed a distinguished academic profile through sustained contributions to reproductive medicine, endocrinology, and clinical research. Her scholarly achievements, supported by substantial publication output and citation impact, demonstrate continued engagement with important biomedical questions. These accomplishments provide a strong foundation for consideration within the International Research Excellence Awards – Book of Award program.

References

  1. Elsevier. (n.d.). Scopus author details: Rossella Cannarella, Author ID 56033761100. Scopus.
    https://www.scopus.com/authid/detail.uri?authorId=56033761100
  2. Cannarella, R. et al. (2026). Transitioning to Omnipod 5®. Biomedicines.
    DOI: https://doi.org/10.3390/biomedicines14051136
  3. Cannarella, R. et al. (2025). Identification of Novel Genetic Variants in a Cohort of Congenital Hypogonadotropic Hypogonadism. International Journal of Molecular Sciences.
    https://doi.org/10.3390/ijms26115207
  4. Cannarella, R. et al. (2024). Comparison Between Varicocelectomy and Varicocele Sclerotherapy. Life.
    https://doi.org/10.3390/life14111368
  5. Cannarella, R. et al. (2024). Effects of Switching FSH Preparations on Sperm Parameters and Pregnancy. Journal of Clinical Medicine.
    https://doi.org/10.3390/jcm13195666
  6. Cannarella, R. et al. (2024). In-Vitro Effects of Perfluorooctanoic Acid on Human Sperm Function. Journal of Clinical Medicine.
    https://doi.org/10.3390/jcm13082201

Abdullah Al Hamid | Health Professions | King Faisal University

Best Review Article Award

Abdullah Al Hamid
King Faisal University, Saudi Arabia

Abdullah Al Hamid
Affiliation King Faisal University
Country Saudi Arabia
Scopus ID 55966812500
Documents 43
Citations 624
h-index 13
Subject Area Health Professions
Event International Research Excellence Awards – Book of Award
ORCID 0000-0002-7124-557X

The Best Review Article Award recognizes scholarly contributions that demonstrate methodological rigor, analytical depth, and meaningful synthesis of scientific evidence. Abdullah Al Hamid of King Faisal University has established a research profile characterized by interdisciplinary investigations spanning health professions, public health, machine learning applications, nephrology, substance use studies, and evidence-based healthcare evaluation. His publication record reflects sustained engagement with contemporary research challenges and systematic approaches to scientific inquiry.[1]

Abstract

This article presents an academic overview of Abdullah Al Hamid’s research achievements and evaluates their relevance to the Best Review Article Award. His scholarly record demonstrates engagement with systematic reviews, evidence synthesis, public health research, and emerging applications of machine learning within healthcare contexts. The breadth of publications and citation performance indicate a measurable contribution to scientific knowledge dissemination and interdisciplinary research development.[2]

Keywords

Systematic Review, Health Professions, Evidence Synthesis, Public Health, Machine Learning, Drug Research, Academic Impact, Scholarly Excellence.

Introduction

Contemporary research environments increasingly require interdisciplinary approaches that integrate data science, healthcare evaluation, and evidence-based decision-making. Abdullah Al Hamid’s scholarly work reflects these priorities through publications addressing drug detection technologies, health screening utilization, substance abuse assessment, and educational analytics. Such research contributes to the broader understanding of healthcare outcomes and methodological innovation.[3]

Research Profile

With 43 indexed documents, 624 citations, and an h-index of 13, Abdullah Al Hamid has developed a recognized publication record within health-related disciplines. His research interests encompass nephrology, healthcare screening practices, substance misuse studies, spectroscopy-based detection systems, and machine learning methodologies. The diversity of topics demonstrates an ability to engage with both applied and theoretical research challenges.[1]

Research Contributions

  • Systematic evaluation of albuminuria screening practices among adults with diabetes and hypertension.
  • Investigation of steroid and illicit drug abuse within health and fitness communities.
  • Application of machine learning algorithms for educational performance classification.
  • Development of spectroscopy-based methods for drug detection in beverages.
  • Assessment of hallucinogenic new psychoactive substances through digital and behavioral perspectives.

Publications

Representative publications include studies published in Journal of Drug Issues, BMC Nephrology, Emerging Trends in Drugs, Addictions, and Health, and the Lecture Notes on Data Engineering and Communications Technologies series. These works collectively illustrate engagement with systematic review methodologies, public health investigations, and technological innovation.[4]

Research Impact

The citation profile associated with Abdullah Al Hamid’s publications suggests sustained academic visibility and relevance. His research contributes evidence that may support healthcare policy evaluation, screening program effectiveness, substance abuse awareness, and the implementation of data-driven analytical techniques. The combination of review-based and empirical research strengthens the practical value of his scholarly portfolio.[5]

Award Suitability

The Best Review Article Award emphasizes scholarly synthesis, methodological transparency, and contribution to knowledge advancement. Abdullah Al Hamid’s record includes systematic reviews and evidence-based investigations addressing clinically and socially significant topics. The documented publication output, citation performance, and interdisciplinary scope support consideration for recognition within the International Research Excellence Awards – Book of Award program.[6]

Conclusion

Abdullah Al Hamid’s academic achievements demonstrate a sustained commitment to evidence-based research, interdisciplinary collaboration, and scholarly dissemination. His contributions to healthcare-related research, systematic review literature, and machine learning applications highlight a profile aligned with the objectives of academic excellence and research recognition programs.[1]

References

  1. Elsevier. (n.d.). Scopus author details: Abdullah Al Hamid, Author ID 55966812500. Scopus.
    https://www.scopus.com/authid/detail.uri?authorId=55966812500
  2. Al Hamid, A. (2026). Effects and Toxicity of Hallucinogenic New Psychoactive Substances From the Perspectives of e-Psychonauts. Journal of Drug Issues.
    DOI: https://doi.org/10.1177/00220426241283690
  3. Al Hamid, A. (2026). Classifying Students’ Performance in Mathematics in a Multicultural Primary School Using Machine Learning Algorithms.
    DOI: https://doi.org/10.1007/978-981-96-7749-8_12
  4. Al Hamid, A. (2026). Detection of Drugs in Spiked Drinks Using Handheld Infrared and Raman Spectroscopy and Machine Learning Algorithms.
    DOI: https://doi.org/10.1007/978-981-96-7749-8_27
  5. Al Hamid, A. (2026). Underutilization of albuminuria screening in adults with diabetes mellitus or hypertension: a systematic review and meta-analysis. BMC Nephrology.
    DOI: https://doi.org/10.1186/s12882-025-04672-5
  6. Al Hamid, A. (2025). Steroid and illicit drug abuse in the health and fitness community: A systematic review of evidence. Emerging Trends in Drugs, Addictions, and Health.
    DOI: https://doi.org/10.1016/j.etdah.2025.100172

Dan Xu | Immunology and Microbiology | Innovative Research Award

Innovative Research Award

Dan Xu
Shanghai Jiao Tong University School of Medicine, China
Dan Xu
Affiliation Shanghai Jiao Tong University School of Medicine
Country China
Scopus ID 57077384300
Documents 39
Citations 891
h-index 17
Subject Area Immunology and Microbiology
Event International Research Excellence Awards – Book of Award
ORCID 0000-0001-7769-5187

Dan Xu is a researcher affiliated with Shanghai Jiao Tong University School of Medicine whose scholarly contributions have focused on immunology, inflammatory diseases, sepsis, pancreatic disorders, and the immune microenvironment. Her research portfolio demonstrates active engagement in translational biomedical investigations that combine molecular biology, bioinformatics, Mendelian randomization, and immunological analysis to better understand disease mechanisms and therapeutic opportunities. Through publications indexed in major international databases, her work has contributed to advancing knowledge in acute pancreatitis, sepsis-associated complications, pancreatic cancer biology, and immune-mediated pathological processes.[1]

Abstract

Dan Xu’s research activities focus on elucidating the immunological and molecular mechanisms underlying inflammatory diseases, sepsis progression, and pancreatic pathology. Her studies integrate advanced computational approaches with experimental biomedical investigations, contributing valuable evidence regarding immune-cell interactions, metabolic regulation, extracellular vesicle biology, and disease-associated inflammatory pathways. The body of work reflects a multidisciplinary approach aimed at improving disease characterization and supporting future therapeutic development.[2]

Keywords

Pancreatitis, Immune Microenvironment, Sepsis, Inflammation, Pancreatic Cancer, Extracellular Vesicles, Mendelian Randomization, Immunology.

Introduction

The growing burden of inflammatory and immune-mediated diseases has increased demand for research capable of revealing disease mechanisms at cellular and molecular levels. Dan Xu’s work addresses this challenge by investigating the relationship between immune responses, metabolic pathways, and disease progression. Her studies have explored both clinical and experimental dimensions of acute pancreatitis, sepsis, and pancreatic cancer, providing insights into biological processes that may influence patient outcomes.[3]

Research Profile

With documented publications and a recognized citation record, Dan Xu has developed expertise in immunology and microbiology. Her scholarly interests include immune microenvironment regulation, inflammatory signaling, pancreatic disease mechanisms, and translational biomedical research. She has also employed bioinformatics and genomics-based methodologies to investigate disease-associated cellular responses and therapeutic targets.[1]

Research Contributions

  • Investigation of immune traits associated with acute pancreatitis progression to sepsis.
  • Research on extracellular vesicles derived from mesenchymal stem cells and inflammatory regulation.
  • Application of Mendelian randomization methods to inflammatory and metabolic disease pathways.
  • Analysis of endoplasmic-reticulum-stress-mediated cellular injury in acute pancreatitis.
  • Studies examining pancreatic cancer progression and tumor microenvironment interactions.

Publications

  • Citric acid promotes SPARC release in pancreatic cancer cells and inhibits pancreatic tumor progression.
  • Dissecting the mediating role of inflammatory factors in metabolites and sepsis.
  • MSCs-derived extracellular vesicles alleviate sepsis-associated liver dysfunction.
  • Single-cell and bulk RNA-seq atlas reveals ERS-mediated acinar cell damage in acute pancreatitis.

Research Impact

The research output associated with Dan Xu demonstrates measurable academic visibility through citations and interdisciplinary engagement. Her investigations contribute to understanding inflammatory disease mechanisms and support ongoing efforts to identify biomarkers, therapeutic targets, and evidence-based intervention strategies. The integration of computational and experimental approaches further enhances the relevance of her findings within modern biomedical research.[4]

Award Suitability

Dan Xu’s publication record, citation performance, and contributions to immunology and inflammatory disease research align with the objectives of the Innovative Research Award. Her work reflects scientific rigor, methodological diversity, and continued engagement in research areas that have significant implications for human health and disease management. These achievements support recognition within international research excellence programs.[5]

Conclusion

Dan Xu has established a notable academic profile through contributions to immunology, sepsis research, pancreatic disease studies, and translational biomedical science. Her research portfolio illustrates a commitment to advancing scientific understanding through data-driven and experimental investigations. The breadth and impact of her work underscore her relevance within contemporary biomedical research and academic recognition initiatives.

References

  1. Elsevier. (n.d.). Scopus author details: Dan Xu, Author ID 57077384300. Scopus.
    https://www.scopus.com/authid/detail.uri?authorId=57077384300
  2. Xu, D. et al. (2024). MSCs-derived extracellular vesicles alleviate sepsis-associated liver dysfunction.
    https://doi.org/10.1016/j.intimp.2024.111575
  3. Xu, D. et al. (2024). ERS-mediated acinar cell damage in acute pancreatitis.
    https://doi.org/10.1186/s12967-024-05156-0
  4. Xu, D. et al. (2024). Immune cell traits and acute pancreatitis progression to sepsis.
    https://doi.org/10.3389/fimmu.2024.1374787
  5. Xu, D. et al. (2024). Inflammatory factors in metabolites and sepsis.
    https://doi.org/10.3389/fendo.2024.1377755
  6. Xu, D. et al. (2024). Citric acid promotes SPARC release in pancreatic cancer cells.
    https://doi.org/10.1111/febs.17058